These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8311492)

  • 1. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activities of oily suspended zinostatin stimalamer (YM 881) against VX2 carcinoma implanted in the liver of rabbits--comparison with another anticancer agent].
    Oda T; Konno T; Ohtsuka N; Kimura M; Mizumachi R
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2423-8. PubMed ID: 1835341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension].
    Toge T; Jinushi K; Sawamura A; Matsuki K
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor.
    Hayashi Y; Fukushima S; Kishimoto S; Kawaguchi T; Numata M; Isoda Y; Hirano J; Nakano M
    Cancer Res; 1992 Jan; 52(2):400-5. PubMed ID: 1309442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881].
    Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined treatment with intra-arterial administration of oily anti-cancer agents and transcatheter arterial embolization--clinical and pathological study on 2 cases with resected small hepatoma].
    Tokuyama K; Jinno K; Yumoto Y; Takasima S; Fukuda K; Moriwaki S; Maeda H; Shimamura Y
    Gan No Rinsho; 1984 Jul; 30(8):955-64. PubMed ID: 6088831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K; Saitoh S; Kumada H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An anaphylactic shock case after hepatic arterial infusion of zinostatin stimalamer suspension improved by anti-histaminics].
    Fukuhara K; Suzuki M; Unno M; Rikiyama T; Sakamoto N; Takeuchi H; Uchiyama T; Yamaki T; Iwasashi H; Kodama H; Matsuno S
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):1023-6. PubMed ID: 9212813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].
    Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
    Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
    Konno T; Maeda H; Yokoyama I; Iwai K; Ogata K; Tashiro S; Uemura K; Mochinaga M; Watanabe E; Nakakuma K; Morinaga T; Miyauchi Y
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinoma.
    Ishii H; Furuse J; Nagase M; Maru Y; Yoshino M; Hayashi T
    Jpn J Clin Oncol; 2003 Nov; 33(11):570-3. PubMed ID: 14711981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.